Last updated: Oct 30, 2026, 12:00 AM

Gain Therapeutics Inc Exchange (NASDAQ, USD)

GANX

1.20
+0.03 (+2.14%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-38.72%
3 year return (CAGR)
-26.58%
5 year return (CAGR)
-29.41%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
52.15M
Price/Sales
-
Ent value
43.20M
Price/Book
4.62
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
0.03%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open1.16
Daily high1.20
Daily low1.16
Daily Volume400K
All-time high15.80
1y analyst estimate7.25
Beta0.21
EPS (TTM)-0.47
Dividend per share0.00
Ex-div date-
Next earnings date19 Mar 2026

Ready to capitalize on Gain Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
GANXS&P500
Current price drop from All-time high-92.44%-0.87%
Highest price drop-94.08%-56.47%
Date of highest drop13 Aug 20249 Mar 2009
Avg drop from high-76.38%-10.65%
Avg time to new high157 days12 days
Max time to new high1400 days1805 days